Author: LEE ERICA H. BUSAM KLAUS J.
Publisher: Elsevier
ISSN: 1076-0512
Source: Dermatologic Surgery, Vol.37, Iss.11, 2011-11, pp. : 1689-1692
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Vemurafenib: Development of resistance during treatment for malignant melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1373, 2011-01 ,pp. :
Fingolimod: Melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1372, 2011-01 ,pp. :
Natalizumab: Malignant melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1341, 2011-01 ,pp. :
Alemtuzumab: Malignant melanoma: case report
Reactions Weekly, Vol. 1, Iss. 1250, 2009-01 ,pp. :